Associations between serum ferritin baselines and trajectories and the incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study

被引:1
作者
Song, Ziping [1 ,2 ]
Miao, Xinlei [1 ]
Xie, Xiaoling [3 ]
Tang, Guimin [3 ]
Deng, Jiayi [2 ]
Hu, Manling [2 ]
Liu, Shuang [3 ]
Leng, Song [1 ,2 ]
机构
[1] Dalian Med Univ, Hosp 2, Hlth Management Ctr, Dalian 116023, Liaoning, Peoples R China
[2] Dalian Med Univ, Hosp 2, Dept Gastroenterol, Dalian 116023, Liaoning, Peoples R China
[3] Dalian Med Univ, Sch Publ Hlth, Dalian 116000, Liaoning, Peoples R China
关键词
Serum ferritin; Metabolic dysfunction-associated steatotic liver disease; Risk factor; Group-based trajectory modeling; Restricted cubic spline; Time-dependent receiver operating characteristic; IRON; PROGRESSION; POPULATION; FIBROSIS; RECEPTOR; INSULIN; INDEX; RISK;
D O I
10.1186/s12944-024-02129-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background and aims Evidence from prospective cohort studies on the relationship between metabolic dysfunction-associated steatotic liver disease (MASLD) and longitudinal changes in serum ferritin (SF) still limited. This study aimed to investigate the associations of SF baselines and trajectories with new-onset MASLD and to present a MASLD discriminant model. Methods A total of 1895 participants who attended health examinations at least three times in a hospital in Dalian City between 2015 and 2022 were included. The main outcome was the incidence of MASLD. The associations between SF baselines and trajectories with the risk of MASLD were analyzed by Cox proportional hazards regression, restricted cubic spline (RCS) analysis and time-dependent receiver operating characteristic (ROC) curve analysis. In addition, a MASLD discrimination model was established using logistic regression analyses. Results Among the 1895 participants, 492 developed MASLD during follow-up. Kaplan-Meier analysis indicated that participants in the low-stable trajectory group had a longer MASLD-free time compared with participants in other groups. Compared with those in the low-stable trajectory group, the adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) for the risk of new-onset MASLD in the medium-high, high-stable and high-high trajectory groups were 1.54(1.18-2.00), 1.77(1.35-2.32) and 1.55(1.07-2.26), respectively (P trend < 0.001). The results were robust in subgroup and sensitivity analyses. Multivariate Cox proportional regression showed that SF was an independent risk factor of MASLD (HR = 1.002, 95%CI: 1.000-1.003, P = 0.003). The restricted cubic spline demonstrated a nonlinear relationship between SF and the risk of MASLD. The 8-variable model had high discriminative performance, good accuracy and clinical effectiveness. The ROC curve results showed that AUC was greater than that of the FLI, HSI and ZJU models (all P < 0.01). Conclusions Not only a higher baseline SF but also SF changing trajectory are significantly associated with risk of new-onset MASLD. SF could be a predictor of the occurrence of MASLD.
引用
收藏
页数:12
相关论文
共 42 条
  • [1] Relationship between indices of iron status and coronary risk factors including diabetes and the metabolic syndrome in Saudi subjects without overt coronary disease
    Alissa, Ernan M.
    Ahmed, Waqar H.
    Al-Ama, Nabeel
    Ferns, Gordon A. A.
    [J]. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2007, 21 (04) : 242 - 254
  • [2] [Anonymous], 2001, JAMA, V285, P2486, DOI DOI 10.1001/JAMA.285.19.2486
  • [3] The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
    Bedogni, Giorgio
    Bellentani, Stefano
    Miglioli, Lucia
    Masutti, Flora
    Passalacqua, Marilena
    Castiglione, Anna
    Tiribelli, Claudio
    [J]. BMC GASTROENTEROLOGY, 2006, 6 (1)
  • [4] Estrogen Signals Through Peroxisome Proliferator-Activated Receptor - γ Coactivator 1α to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease
    Besse-Patin, Aurele
    Leveille, Melissa
    Oropeza, Daniel
    Nguyen, Bich N.
    Prat, Annik
    Estall, Jennifer L.
    [J]. GASTROENTEROLOGY, 2017, 152 (01) : 243 - 256
  • [5] Iron and non-alcoholic fatty liver disease
    Britton, Laurence J.
    Subramaniam, V. Nathan
    Crawford, Darrell H. G.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (36) : 8112 - 8122
  • [6] Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2019
    Cefalu, William T.
    Berg, Erika Gebel
    Saraco, Mindy
    Petersen, Matthew P.
    Uelmen, Sacha
    Robinson, Shamera
    [J]. DIABETES CARE, 2019, 42 : S34 - S45
  • [7] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian, AV
    Bakris, GL
    Black, HR
    Cushman, WC
    Green, LA
    Izzo, JL
    Jones, DW
    Materson, BJ
    Oparil, S
    Wright, JT
    Roccella, EJ
    [J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
  • [8] Iron overload and non-alcoholic fatty liver disease
    Datz, Christian
    Mueller, Elena
    Aigner, Elmar
    [J]. MINERVA ENDOCRINOLOGICA, 2017, 42 (02) : 173 - 183
  • [9] A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
    Eslam, Mohammed
    Newsome, Philip N.
    Sarin, Shiv K.
    Anstee, Quentin M.
    Targher, Giovanni
    Romero-Gomez, Manuel
    Zelber-Sagi, Shira
    Wong, Vincent Wai-Sun
    Dufour, Jean-Francois
    Schattenberg, Joern M.
    Kawaguchi, Takumi
    Arrese, Marco
    Valenti, Luca
    Shiha, Gamal
    Tiribelli, Claudio
    Yki-Jarvinen, Hannele
    Fan, Jian-Gao
    Gronbaek, Henning
    Yilmaz, Yusuf
    Cortez-Pinto, Helena
    Oliveira, Claudia P.
    Bedossa, Pierre
    Adams, Leon A.
    Zheng, Ming-Hua
    Fouad, Yasser
    Chan, Wah-Kheong
    Mendez-Sanchez, Nahum
    Ahn, Sang Hoon
    Castera, Laurent
    Bugianesi, Elisabetta
    Ratziu, Vlad
    George, Jacob
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 (01) : 202 - 209
  • [10] Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity
    Fracanzani, Anna Ludovica
    Valenti, Luca
    Bugianesi, Elisabetta
    Vanni, Ester
    Grieco, Antonio
    Miele, Luca
    Consonni, Dario
    Fatta, Erika
    Lombardi, Rosa
    Marchesini, Giulio
    Fargion, Silvia
    [J]. JOURNAL OF HEPATOLOGY, 2011, 54 (06) : 1244 - 1249